Ontology highlight
ABSTRACT: Background
The mechanisms underlying tolerance induction and maintenance in autoimmune arthritis remain elusive. In a mouse model of rheumatoid arthritis, collagen type II (CII)-induced arthritis, we explore the contribution of B cells to antigen-specific tolerance.Methods
To generate expression of the CII-peptide specifically on B-cell major histocompatibility complex type II, lentiviral-based gene therapy including a B-cell-specific Igk promoter was used.Results
Presentation of the CII-peptide on B cells significantly reduced the frequency and severity of arthritis as well as the serum levels of CII -specific IgG antibodies. Further, both frequency and suppressive function of regulatory T cells were increased in tolerized mice. Adoptive transfer of regulatory T cells from tolerized mice to naïve mice ameliorated the development of CII-induced arthritis.Conclusion
Our data suggest that endogenous presentation of the CII-peptide on B cells is one of the key contributors to arthritis tolerance induction and maintenance.
SUBMITTER: Andersson SE
PROVIDER: S-EPMC4908726 | biostudies-literature | 2016 Jun
REPOSITORIES: biostudies-literature
Andersson Sofia E M SE Eneljung Tove T Tengvall Sara S Jirholt Pernilla P Stern Anna A Henningsson Louise L Liang Bibo B Thorarinsdottir Katrin K Kihlberg Jan J Holmdahl Rikard R Mårtensson Inga-Lill IL Gustafsson Kenth K Gjertsson Inger I
Arthritis research & therapy 20160614 1
<h4>Background</h4>The mechanisms underlying tolerance induction and maintenance in autoimmune arthritis remain elusive. In a mouse model of rheumatoid arthritis, collagen type II (CII)-induced arthritis, we explore the contribution of B cells to antigen-specific tolerance.<h4>Methods</h4>To generate expression of the CII-peptide specifically on B-cell major histocompatibility complex type II, lentiviral-based gene therapy including a B-cell-specific Igk promoter was used.<h4>Results</h4>Present ...[more]